Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: A New European Union-Approved Etanercept Biosimilar (Benepali<sup>®</sup>) Versus Etanercept (Enbrel<sup>®</sup>) - Findings from a Nurse Survey in Europe.

导出 LinkOut

翻译打印收藏纠错

作者： Kunal,Thakur ^[1] ; Anna,Biberger ^[2] ; Alexandra,Handrich ^[3] ; Mourad Farouk,Rezk ^[3]

作者单位： Biogen International GmbH, Zug, Switzerland. Kunal.thakur@biogen.com. ^[1] Kantar Health GmbH, Munich, Germany. ^[2] Biogen International GmbH, Zug, Switzerland. ^[3]

关键词 Autoinjector Benepali Biosimilar Enbrel Etanercept Nurses Rheumatoid arthritis

DOI 10.1007/s40744-016-0035-1

PMID 27747519

发布时间 2020-09-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览51

Rheumatology and therapy

2016年3卷1期

77-89页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: A New European Union-Approved Etanercept Biosimilar (Benepali<sup>®</sup>) Versus Etanercept (Enbrel<sup>®</sup>) - Findings from a Nurse Survey in Europe.

Rheumatology and therapy

相似文献

Rheumatology and therapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Perceptions and Preferences of Two Etanercept Autoinjectors for Rheumatoid Arthritis: A New European Union-Approved Etanercept Biosimilar (Benepali<sup>®</sup>) Versus Etanercept (Enbrel<sup>®</sup>) - Findings from a Nurse Survey in Europe.

Rheumatology and therapy

相似文献

Rheumatology and therapy

相关期刊

检索历史清除